197 related articles for article (PubMed ID: 27123533)
21. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
22. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?
Licht AS; Murphy JM; Hyland AJ; Fix BV; Hawk LW; Mahoney MC
Sex Transm Infect; 2010 Feb; 86(1):74-8. PubMed ID: 19841004
[TBL] [Abstract][Full Text] [Related]
23. Canadian school-based HPV vaccine programs and policy considerations.
Shapiro GK; Guichon J; Kelaher M
Vaccine; 2017 Oct; 35(42):5700-5707. PubMed ID: 28893472
[TBL] [Abstract][Full Text] [Related]
24. Barriers to human papillomavirus vaccine acceptability in Israel.
Fisher WA; Laniado H; Shoval H; Hakim M; Bornstein J
Vaccine; 2013 Nov; 31 Suppl 8():I53-7. PubMed ID: 24229720
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
Flaherty DK; Alkhateeb FM
Ann Pharmacother; 2009 Apr; 43(4):740-4. PubMed ID: 19276314
[TBL] [Abstract][Full Text] [Related]
26. [Research progression of prophylactic HPV vaccine application].
Zhang L; Zhao FH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):724-728. PubMed ID: 30392335
[TBL] [Abstract][Full Text] [Related]
27. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes.
Kahn JA; Zimet GD; Bernstein DI; Riedesel JM; Lan D; Huang B; Rosenthal SL
J Adolesc Health; 2005 Dec; 37(6):502-10. PubMed ID: 16310128
[TBL] [Abstract][Full Text] [Related]
28. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
[TBL] [Abstract][Full Text] [Related]
29. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.
Lehtinen M; Apter D
Curr Opin Obstet Gynecol; 2015 Oct; 27(5):326-32. PubMed ID: 26308204
[TBL] [Abstract][Full Text] [Related]
30. Risk messages about HPV, cervical cancer, and the HPV vaccine gardasil in North American news magazines.
Abdelmutti N; Hoffman-Goetz L
J Cancer Educ; 2010 Sep; 25(3):451-6. PubMed ID: 20232189
[TBL] [Abstract][Full Text] [Related]
31. 9-Valent human papillomavirus vaccine: a review of the clinical development program.
Luxembourg A; Moeller E
Expert Rev Vaccines; 2017 Nov; 16(11):1119-1139. PubMed ID: 28956458
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus Vaccination in Washington State: Estimated Coverage and Missed Opportunities, 2006-2013.
Oltean HN; Lofy KH; Goldoft MJ; DeBolt CA
Public Health Rep; 2016; 131(3):474-82. PubMed ID: 27252567
[TBL] [Abstract][Full Text] [Related]
33. HPV vaccines to prevent cervical cancer and genital warts: an update.
Dochez C; Bogers JJ; Verhelst R; Rees H
Vaccine; 2014 Mar; 32(14):1595-601. PubMed ID: 24606637
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases.
Skinner SR; Apter D; De Carvalho N; Harper DM; Konno R; Paavonen J; Romanowski B; Roteli-Martins C; Burlet N; Mihalyi A; Struyf F
Expert Rev Vaccines; 2016; 15(3):367-87. PubMed ID: 26902666
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with HPV vaccine uptake in teenage girls: a systematic review.
Kessels SJ; Marshall HS; Watson M; Braunack-Mayer AJ; Reuzel R; Tooher RL
Vaccine; 2012 May; 30(24):3546-56. PubMed ID: 22480928
[TBL] [Abstract][Full Text] [Related]
36. Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005-2008).
Hilton S; Hunt K; Langan M; Bedford H; Petticrew M
Soc Sci Med; 2010 Mar; 70(6):942-50. PubMed ID: 20064682
[TBL] [Abstract][Full Text] [Related]
37. HPV vaccination in boys and men.
Stanley M
Hum Vaccin Immunother; 2014; 10(7):2109-11. PubMed ID: 25424825
[TBL] [Abstract][Full Text] [Related]
38. Perceptions of politicization and HPV vaccine policy support.
Saulsberry L; Fowler EF; Nagler RH; Gollust SE
Vaccine; 2019 Aug; 37(35):5121-5128. PubMed ID: 31296376
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Chesson HW; Curtis CR; Gee J; Bocchini JA; Unger ER;
MMWR Recomm Rep; 2014 Aug; 63(RR-05):1-30. PubMed ID: 25167164
[TBL] [Abstract][Full Text] [Related]
40. Newspaper coverage before and after the HPV vaccination crisis began in Japan: a text mining analysis.
Okuhara T; Ishikawa H; Okada M; Kato M; Kiuchi T
BMC Public Health; 2019 Jun; 19(1):770. PubMed ID: 31208394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
